Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!
Kathy V. Turner, insider at IDEXX Laboratories
Kathy V. Turner Insider Alerts

Get notified the next time Kathy V. Turner buys or sells IDEXX Laboratories stock. Enter your email address below to get our daily insider buying and selling report.

Kathy V. Turner Insider Information

Ms. Turner has been a Senior Vice President of IDEXX since May 2014 and the Chief Marketing Officer of IDEXX since January 2020. Prior to becoming the Chief Marketing Officer, she led the company’s Europe, Middle East and Africa (EMEA) Companion Animal Commercial Operations and the company's Asia Pacific Companion Animal, Water, Livestock, Poultry and Dairy Commercial Operations. Prior to joining the company, from 1987 to May 2014, Ms. Turner held various leadership positions with increasing responsibilities at Abbott Laboratories, Inc., a broad-based healthcare company that manufactures and markets pharmaceuticals, medical products and diagnostics. Most recently, Ms. Turner was Divisional Vice President of European Commercial Operations for the Diagnostics Division from 2011 to 2014, and prior to that, Divisional Vice President of Global Strategic Operations for the Diagnostics Division from 2007 to 2011. Ms. Turner holds a bachelor’s degree in marketing and advertising from Syracuse University.

What is Kathy V. Turner's net worth?

The estimated net worth of Kathy V. Turner is at least $1.69 million as of May 28th, 2021. Ms. Turner owns 2,886 shares of IDEXX Laboratories stock worth more than $1,692,754 as of December 5th. This net worth approximation does not reflect any other assets that Ms. Turner may own. Learn More.

How do I contact Kathy V. Turner?

The corporate mailing address for Ms. Turner and other IDEXX Laboratories executives is ONE IDEXX DRIVE, WESTBROOK ME, 04092. IDEXX Laboratories can also be reached via phone at (207) 556-0300 and via email at [email protected]

Has Kathy V. Turner been buying or selling shares of IDEXX Laboratories?

Kathy V. Turner has not been actively trading shares of IDEXX Laboratories during the past quarter. Most recently, Kathy V. Turner sold 2,250 shares of the business's stock in a transaction on Monday, August 30th. The shares were sold at an average price of $687.22, for a transaction totalling $1,546,245.00.

Who are IDEXX Laboratories' active insiders?

IDEXX Laboratories' insider roster includes Jonathan Ayers (Director), Nimrata Hunt (EVP), Daniel Junius (Director), Michael Lane (EVP), Brian Mckeon (CFO), James Polewaczyk (EVP), M. Szostak (Director), Kathy Turner (SVP), Kathy Turner (SVP), and Giovani Twigge (SVP).

Are insiders buying or selling shares of IDEXX Laboratories?

During the last year, insiders at the sold shares 24 times. They sold a total of 113,938 shares worth more than $66,392,641.61. The most recent insider tranaction occured on November, 29th when EVP James F Polewaczyk sold 4,595 shares worth more than $2,908,635.00. Insiders at IDEXX Laboratories own 2.1 % of the company.

Information on this page was last updated on 11/29/2021.

Kathy V. Turner Insider Trading History at IDEXX Laboratories

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/30/2021Sell2,250$687.22$1,546,245.00View SEC Filing Icon  
8/27/2021Sell276$678.00$187,128.00View SEC Filing Icon  
5/28/2021Sell2,000$558.44$1,116,880.002,886View SEC Filing Icon  
5/24/2021Sell2,900$546.24$1,584,096.006,866View SEC Filing Icon  
See Full Table

Kathy V. Turner Buying and Selling Activity at IDEXX Laboratories

This chart shows Kathy V Turner's buying and selling at IDEXX Laboratories by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

IDEXX Laboratories Company Overview

IDEXX Laboratories logo
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. It operates through the following segments: CAG, Water, LPD, and Other. The CAG segment develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services, which are used to manage the health status of livestock and poultry, to improve producer, and to ensure the quality and safety of milk and food. The Other operating segment combines and presents products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983 and is headquartered in Westbrook, ME.
Read More

Today's Range

Now: $586.54
Low: $575.59
High: $608.11

50 Day Range

MA: $629.13
Low: $586.54
High: $666.48

2 Week Range

Now: $586.54
Low: $447.82
High: $706.95

Volume

451,889 shs

Average Volume

337,249 shs

Market Capitalization

$49.73 billion

P/E Ratio

67.19

Dividend Yield

N/A

Beta

0.94
Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!